Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDL

被引:46
|
作者
Muellner, Markus K. [1 ]
Schreier, Sabine M. [1 ]
Laggner, Hilde [1 ]
Hermann, Marcela [2 ]
Esterbauer, Harald [3 ]
Exner, Markus [4 ]
Gmeiner, Bernhard M. K. [1 ]
Kapiotis, Stylianos [3 ,5 ]
机构
[1] Med Univ Vienna, CPP, Dept Med Chem, Vienna, Austria
[2] Med Univ Vienna, MFPL, Dept Med Biochem, Vienna, Austria
[3] Med Univ Vienna, Clin Inst Med & Chem Lab Diagnost, Vienna, Austria
[4] Spitzauer & Partner, Labor Gruppenpraxis Bauer, Vienna, Austria
[5] Hosp Div Redeemer, Cent Lab, Vienna, Austria
关键词
atherosclerosis; hydrogen sulfide (H2S); low-densitylipoprotein (LDL) oxidation; lipid hydroperoxide; (9-S)-hydroxy-(10E; 12Z)-octadecadienoic acid (9-HODE); (9S)-hydroperoxy-(10E; 12Z)-octadecadienoic acid (9-HPODE); LOW-DENSITY-LIPOPROTEIN; HEME OXYGENASE-1; OXIDATIVE MODIFICATION; PEROXIDATION PRODUCTS; PARAOXONASE; CHOLESTEROL; INHIBITOR; INDUCTION; MECHANISM; IONS;
D O I
10.1042/BJ20082421
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
LOOHs (lipid hydroperoxides) in oxLDL oxidized LDL (low-density lipoprotein) are potentially atherogenic compounds. Recently, H2S was identified as the third endogenous gasotransmitter in the vasculature. H2O2 is known to be destroyed by H2S. Assuming that H2S may also react with LOOHs, the results show that H2S can destroy LOOHs in oxLDL. The ability of LOOH-enriched LDL to induce HO-1 (haem oxygenase 1) in endothelial cells was abolished by 1-I,S pretreatment. I-IPLC analysis showed that 9-HPODE [(9S)-hydroperoxy-(10E,12Z)octadecadienoic acid], a compound found in oxLDL, was reduced to 9-HODS [(9S)-hydroxy-(10E,12Z)-octadecadienoic acid] in the presence of H2S. Thus H2S may act its an antiatherogenic agent by reducing LOOHS to the less reactive LOHs and could abrogate the pathobiological activity of oxLDL.
引用
收藏
页码:277 / 281
页数:5
相关论文
共 50 条
  • [21] Quantitative determination of phosphatidylcholine hydroperoxides during copper oxidation of LDL and HDL by liquid chromatography/mass spectrometry
    Hui, Shu-Ping
    Taguchi, Yudai
    Takeda, Seiji
    Ohkawa, Futaba
    Sakurai, Toshihiro
    Yamaki, Shinobu
    Jin, Shigeki
    Fuda, Hirotoshi
    Kurosawa, Takao
    Chiba, Hitoshi
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2012, 403 (07) : 1831 - 1840
  • [22] Circulating oxidized LDL: a biomarker and a pathogenic factor
    Ishigaki, Yasushi
    Oka, Yoshitomo
    Katagiri, Hideki
    CURRENT OPINION IN LIPIDOLOGY, 2009, 20 (05) : 363 - 369
  • [23] Oxidized LDL, statin use, morbidity, and mortality in patients receiving maintenance hemodialysis
    Wagner, Sandra
    Apetrii, Mugurel
    Massy, Ziad A.
    Kleber, Marcus E.
    Delgado, Graciela E.
    Scharnagel, Hubert
    Maerz, Winfried
    Metzger, Marie
    Rossignol, Patrick
    Jardine, Alan
    Holdaas, Hallvard
    Fellstroem, Bengt
    Schmieder, Roland
    Stengel, Benedicte
    Zannad, Faiez
    FREE RADICAL RESEARCH, 2017, 51 (01) : 14 - 23
  • [24] Lipopolysaccharide augments the uptake of oxidized LDL by up-regulating lectin-like oxidized LDL receptor-1 in macrophages
    Hossain, Ekhtear
    Ota, Akinobu
    Karnan, Sivasundaram
    Takahashi, Miyuki
    Mannan, Shahnewaj B.
    Konishi, Hiroyuki
    Hosokawa, Yoshitaka
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2015, 400 (1-2) : 29 - 40
  • [25] Immunological responses to oxidized LDL
    Hörkkö, S
    Binder, CJ
    Shaw, PX
    Chang, MK
    Silverman, G
    Palinski, W
    Witztum, JL
    FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (12) : 1771 - 1779
  • [26] LDL oxidation by activated monocytes: characterization of the oxidized LDL and requirement for transition metal ions
    Xing, XY
    Baffic, J
    Sparrow, CP
    JOURNAL OF LIPID RESEARCH, 1998, 39 (11) : 2201 - 2208
  • [27] Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice
    Tsimikas, S
    Palinski, W
    Witztum, JL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (01) : 95 - 100
  • [28] Oxidized LDL and the metabolic syndrome
    Holvoet, Paul
    De Keyzer, Dieuwke
    Jacobs, David R., Jr.
    FUTURE LIPIDOLOGY, 2008, 3 (06): : 637 - 649
  • [29] Role of oxidized LDL in atherosclerosis
    Kita, T
    Kume, N
    Minami, M
    Hayashida, K
    Murayama, T
    Sano, H
    Moriwaki, H
    Kataoka, H
    Nishi, E
    Horiuchi, H
    Arai, H
    Yokode, M
    ATHEROSCLEROSIS VI, 2001, 947 : 199 - 206
  • [30] Oxidized LDL and LOX-1 in Experimental Sepsis
    Al-Banna, Nadia
    Lehmann, Christian
    MEDIATORS OF INFLAMMATION, 2013, 2013